Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

Sinil Pharmaceutical Revenue

Sinil Pharmaceutical had revenue of 19.25B KRW in the quarter ending March 31, 2025, a decrease of -15.46%. This brings the company's revenue in the last twelve months to 85.92B, down -4.60% year-over-year. In the year 2024, Sinil Pharmaceutical had annual revenue of 89.44B with 0.34% growth.

• Revenue (ttm): 85.92B
• Revenue Growth: -4.60%
• P/S Ratio: 0.88
• Revenue / Employee: 299.38M
• Employees: 287
• Market Cap: 75.77B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	89.44B	305.25M	0.34%
Dec 31, 2023	89.14B	9.13B	11.41%
Dec 31, 2022	80.01B	18.25B	29.56%
Dec 31, 2021	61.75B	316.13M	0.51%
Dec 31, 2020	61.44B	789.70M	1.30%